Mark Pruzanski, CEO & President at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 4,127 shares at $145.90 ($602K) on 2016-01-04, disclosed to the SEC on 2016-01-05.
Open-market sale of $602k ICPT by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $145.90 | 125 | $18K | 3.0% |
| 2 | $145.90 | 2,001 | $292K | 48.5% |
| 3 | $145.90 | 2,001 | $292K | 48.5% |
| Total | $145.90 avg | 4,127 | $602K | 100% |
| Filing → |
| ICPT | SELL | 2019-11-27 | $5.0M | — | Filing → |
| ICPT | SELL | 2018-11-16 | $9.1M | — | Filing → |
| ICPT | BUY | 2018-04-09 | $500K | — | Filing → |